Managing Our Microbial Mark: What We Can Learn About Pay for Performance from Ebola's Arrival at Our Shores

36 Pages Posted: 28 Jul 2016

See all articles by Ann Marie Marciarille

Ann Marie Marciarille

University of Missouri at Kansas City - School of Law

Date Written: July 27, 2016

Abstract

The narrative of Ebola’s arrival in the United States has been overwhelmed by our fear of a West African-style epidemic. The real story of Ebola’s arrival is about our healthcare system’s failure to identify, treat, and contain healthcare associated infections. Having long been willfully ignorant of the path of fatal infectious diseases through our healthcare facilities, this paper considers why our reimbursement and quality reporting systems made it easy for this to be so. West Africa’s challenges in controlling Ebola resonate with our own struggles to standardize, centralize, and enforce infection control procedures in American healthcare facilities.

Keywords: Ebola; MRSA; epidemics; healthcare-associated infection; infectious diseases; infection-control; drug-resistant bacteria; reimbursement; hospital-acquired condition; antimicrobial resistance

JEL Classification: I10, I12, I18, K23

Suggested Citation

Marciarille, Ann Marie, Managing Our Microbial Mark: What We Can Learn About Pay for Performance from Ebola's Arrival at Our Shores (July 27, 2016). American Journal of Law and Medicine, Vol. 42, No. 393, 2016. Available at SSRN: https://ssrn.com/abstract=2815049

Ann Marie Marciarille (Contact Author)

University of Missouri at Kansas City - School of Law ( email )

5100 Rockhill Road
Kansas City, MO 64110-2499
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
15
Abstract Views
331
PlumX Metrics